Cabaletta Bio, Inc.

CABA Nasdaq CIK: 0001759138

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2929 ARCH STREET, PHILADELPHIA, PA, 19104
Mailing Address 2929 ARCH STREET, PHILADELPHIA, PA, 19104
Phone (267) 759-3100
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

$53.03M
Total Liabilities
$236.20M
Stockholders' Equity
$-2.10
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 23, 2026 View on SEC
8-K Current report of material events March 23, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 18, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC

Annual Reports

10-K March 23, 2026
  • Advancing lead candidate rese-cel (CAR T cell therapy) in Phase 1/2 RESET clinical trials for autoimmune diseases.
  • Received significant regulatory designations for rese-cel, including Orphan Drug, Rare Pediatric Disease, and Fast Track, which can accelerate development and review.
View Analysis

Insider Trading

BUY 8 insiders 8 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.